This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Copper Cu-64
- DrugBank Accession Number
- DB13980
- Background
Copper-64 is a radiopharmaceutical usually found in the +2 oxidation state as the complexes including the +1 state tend to be more unstable.1 It is used in molecular radiotherapy and positron emission tomography.
- Type
- Small Molecule
- Groups
- Approved
- Structure
Structure for Copper Cu-64 (DB13980)
- Weight
- Average: 63.9298
Monoisotopic: 63.929767865 - Chemical Formula
- Cu
- Synonyms
- Copper, Cu-64
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Product Ingredients
Ingredient UNII CAS InChI Key Cupric chloride anhydrous Cu-64 3IGV2Y2378 35121-64-3 ORTQZVOHEJQUHG-OUMJLSBWSA-L - Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Cuprymina 925 MBq/ml A.C.O.M. Advanced Center Oncology Macerata S.R.L. 2016-09-08 2024-01-25 EU 
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Dermamed Nutrition for troubled skin Copper Cu-64 (1 mg/1.5g) + Ascorbic acid (30 mg/1.5g) + Magnesium aspartate (50 mg/1.5g) + Thiamine chloride (20 mg/1.5g) + Vitamin A (150 [iU]/1.5g) + Vitamin D (150 [iU]/1.5g) + Zinc gluconate (10 mg/1.5g) Capsule, gelatin coated Oral DermaMed 2019-09-18 Not applicable US 
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2MK2L64N0S
- CAS number
- 13981-25-4
- InChI Key
- RYGMFSIKBFXOCR-IGMARMGPSA-N
- InChI
- InChI=1S/Cu/i1+0
- IUPAC Name
- (64Cu)copper
- SMILES
- [64Cu]
References
- General References
- Nairne J., Iveson P. and Meijer A. (2015). Progress in medicinal chemistry (54th ed.). Elsevier.
- External Links
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Parenteral 925 MBQ/ML Capsule, gelatin coated Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0 mg/mL ALOGPS logP -1.3 ALOGPS logP 0.16 Chemaxon logS 1.08 ALOGPS Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 0 m3·mol-1 Chemaxon Polarizability 1.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at January 20, 2018 15:18 / Updated at May 22, 2021 06:02